Product Code: ETC070138 | Publication Date: Jul 2023 | Updated Date: Jan 2024 | Product Type: Report | |
Publisher: 6Wresearch | No. of Pages: 70 | No. of Figures: 35 | No. of Tables: 5 | |
Orphan drugs are pharmaceutical products developed to treat rare diseases or medical conditions that affect a small number of patients. These drugs are often financially incentivized due to the limited market size, which encourages pharmaceutical companies to invest in research and development.
The increasing awareness and diagnosis of rare diseases in Saudi Arabia have driven the demand for orphan drugs tailored to treat these conditions. The Saudi Arabia government`s initiatives to improve healthcare access and promote research and development in the pharmaceutical sector have contributed to the growth of the orphan drugs market. The granting of market exclusivity and financial incentives for orphan drug development encourages pharmaceutical companies to invest in this segment.
Orphan drugs can be expensive due to the smaller patient population, which raises concerns about affordability and access for patients.The small patient pool for rare diseases may lead to challenges in conducting clinical trials and obtaining sufficient data for regulatory approval.
The Covid-19 pandemic may have had varying impacts on the Saudi Arabia Orphan Drugs market. The pandemic`s focus on healthcare preparedness and addressing unmet medical needs may have reinforced the importance of orphan drugs for patients with rare diseases. However, disruptions in healthcare services and access to treatments during the pandemic may have impacted patient care and market dynamics.
Some well-known global pharmaceutical companies with a presence in Saudi Arabia and expertise in orphan drug development include, Novartis AG, Roche Holdings AG, Pfizer Inc., Sanofi SA, and Biogen Inc.
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Saudi Arabia Orphan Drugs Market Overview |
3.1 Saudi Arabia Country Macro Economic Indicators |
3.2 Saudi Arabia Orphan Drugs Market Revenues & Volume, 2020 & 2027F |
3.3 Saudi Arabia Orphan Drugs Market - Industry Life Cycle |
3.4 Saudi Arabia Orphan Drugs Market - Porter's Five Forces |
3.5 Saudi Arabia Orphan Drugs Market Revenues & Volume Share, By Drugs, 2020 & 2027F |
3.6 Saudi Arabia Orphan Drugs Market Revenues & Volume Share, By Drug Type, 2020 & 2027F |
3.7 Saudi Arabia Orphan Drugs Market Revenues & Volume Share, By Therapy Class, 2020 & 2027F |
4 Saudi Arabia Orphan Drugs Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.3 Market Restraints |
5 Saudi Arabia Orphan Drugs Market Trends |
6 Saudi Arabia Orphan Drugs Market, By Types |
6.1 Saudi Arabia Orphan Drugs Market, By Drugs |
6.1.1 Overview and Analysis |
6.1.2 Saudi Arabia Orphan Drugs Market Revenues & Volume, By Drugs, 2018 - 2027F |
6.1.3 Saudi Arabia Orphan Drugs Market Revenues & Volume, By Revlimid, 2018 - 2027F |
6.1.4 Saudi Arabia Orphan Drugs Market Revenues & Volume, By Rituxan, 2018 - 2027F |
6.1.5 Saudi Arabia Orphan Drugs Market Revenues & Volume, By Opdivo, 2018 - 2027F |
6.1.6 Saudi Arabia Orphan Drugs Market Revenues & Volume, By Keytruda, 2018 - 2027F |
6.1.7 Saudi Arabia Orphan Drugs Market Revenues & Volume, By Imbruvica, 2018 - 2027F |
6.1.8 Saudi Arabia Orphan Drugs Market Revenues & Volume, By Soliris, 2018 - 2027F |
6.2 Saudi Arabia Orphan Drugs Market, By Drug Type |
6.2.1 Overview and Analysis |
6.2.2 Saudi Arabia Orphan Drugs Market Revenues & Volume, By Biologics, 2018 - 2027F |
6.2.3 Saudi Arabia Orphan Drugs Market Revenues & Volume, By Non-Biologics, 2018 - 2027F |
6.3 Saudi Arabia Orphan Drugs Market, By Therapy Class |
6.3.1 Overview and Analysis |
6.3.2 Saudi Arabia Orphan Drugs Market Revenues & Volume, By Oncology, 2018 - 2027F |
6.3.3 Saudi Arabia Orphan Drugs Market Revenues & Volume, By Blood, 2018 - 2027F |
6.3.4 Saudi Arabia Orphan Drugs Market Revenues & Volume, By Endocrine, 2018 - 2027F |
6.3.5 Saudi Arabia Orphan Drugs Market Revenues & Volume, By Central Nervous Systems, 2018 - 2027F |
6.3.6 Saudi Arabia Orphan Drugs Market Revenues & Volume, By Cardiovascular, 2018 - 2027F |
6.3.7 Saudi Arabia Orphan Drugs Market Revenues & Volume, By Respiratory, 2018 - 2027F |
7 Saudi Arabia Orphan Drugs Market Import-Export Trade Statistics |
7.1 Saudi Arabia Orphan Drugs Market Export to Major Countries |
7.2 Saudi Arabia Orphan Drugs Market Imports from Major Countries |
8 Saudi Arabia Orphan Drugs Market Key Performance Indicators |
9 Saudi Arabia Orphan Drugs Market - Opportunity Assessment |
9.1 Saudi Arabia Orphan Drugs Market Opportunity Assessment, By Drugs, 2020 & 2027F |
9.2 Saudi Arabia Orphan Drugs Market Opportunity Assessment, By Drug Type, 2020 & 2027F |
9.3 Saudi Arabia Orphan Drugs Market Opportunity Assessment, By Therapy Class, 2020 & 2027F |
10 Saudi Arabia Orphan Drugs Market - Competitive Landscape |
10.1 Saudi Arabia Orphan Drugs Market Revenue Share, By Companies, 2020 |
10.2 Saudi Arabia Orphan Drugs Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |